# Efficacy and Safety Of Spil's Estradiol Vaginal Tablet

> **NCT01753102** · PHASE3 · TERMINATED · sponsor: **Sun Pharmaceutical Industries Limited** · enrollment: 49 (actual)

## Conditions studied

- Vulvar Atrophy
- Vaginal Atrophy

## Interventions

- **DRUG:** Estradiol

## Key facts

- **NCT ID:** NCT01753102
- **Lead sponsor:** Sun Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11-06
- **Primary completion:** 2013-04-30
- **Final completion:** 2013-04-30
- **Target enrollment:** 49 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2018-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01753102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01753102, "Efficacy and Safety Of Spil's Estradiol Vaginal Tablet". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01753102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*